Výsledky vyhledávání - Elizabeth M. Swisher
- Zobrazuji výsledky 1 - 20 z 99
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas Autor Elizabeth M. Swisher, Rachel Gonzalez, Toshiyasu Taniguchi, Rochelle L. Garcia, Tom Walsh, Barbara A. Goff, Piri Welcsh
Vydáno 2009Artigo -
9
-
10
-
11
MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features Autor Heejeong Lee, Chul Soo Park, Georgios Deftereos, Janice Morihara, Joshua Stern, Stephen E. Hawes, Elizabeth M. Swisher, Nancy B. Kiviat, Qinghua Feng
Vydáno 2012Artigo -
12
-
13
-
14
-
15
Secondary Somatic Mutations Restoring<i>BRCA1/2</i>Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas Autor Barbara M. Norquist, Kaitlyn Wurz, Christopher C. Pennil, Rochelle L. Garcia, Jenny Gross, Wataru Sakai, Beth Y. Karlan, Toshiyasu Taniguchi, Elizabeth M. Swisher
Vydáno 2011Artigo -
16
MLH1 Promoter Methylation and Gene Silencing is the Primary Cause of Microsatellite Instability in Sporadic Endometrial Cancers Autor Sally B. Simpkins, T. Bocker, Elizabeth M. Swisher, David G. Mutch, Deborah J. Gersell, Albert J. Kovatich, Juan Palazzo, Richard Fishel, Paul J. Goodfellow
Vydáno 1999Artigo -
17
Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy Autor C. Bethan Powell, Elizabeth M. Swisher, Ilana Cass, J. McLennan, Barbara M. Norquist, Rochelle L. Garcia, Jenny Lester, Beth Y. Karlan, L. Chen
Vydáno 2013Artigo -
18
Functional Restoration of BRCA2 Protein by Secondary<i>BRCA2</i>Mutations in<i>BRCA2</i>-Mutated Ovarian Carcinoma Autor Wataru Sakai, Elizabeth M. Swisher, Céline Jacquemont, Kurapaty Venkatapoorna Chandramohan, Fergus J. Couch, Simon P. Langdon, Kaitlyn Wurz, Jake Higgins, Emily Villegas, Toshiyasu Taniguchi
Vydáno 2009Artigo -
19
Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic <i>TP53</i> mutations in noncancerous tissues Autor Jeffrey D. Krimmel, Michael Schmitt, Maria I. Harrell, Kathy Agnew, Scott R. Kennedy, Mary J. Emond, Lawrence A. Loeb, Elizabeth M. Swisher, Rosa Ana Risques
Vydáno 2016Artigo -
20
Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas Autor Khyati Meghani, Walker Fuchs, Alexandre Detappe, Pascal Drané, Ewa Gogola, Sven Rottenberg, Jos Jonkers, Ursula A. Matulonis, Elizabeth M. Swisher, Panagiotis A. Konstantinopoulos, Dipanjan Chowdhury
Vydáno 2018Artigo
Vyhledávací nástroje:
Související témata
Medicine
Biology
Cancer
Internal medicine
Gene
Genetics
Oncology
Ovarian cancer
Cancer research
Poly ADP ribose polymerase
Polymerase
PARP inhibitor
Mutation
Ovarian carcinoma
Germline mutation
Biochemistry
Chemotherapy
Gynecology
Olaparib
Pathology
DNA
DNA repair
Genetic testing
BRCA mutation
Breast cancer
Cisplatin
Colorectal cancer
DNA mismatch repair
Environmental health
Population